All three doses of Lilly’s drug demonstrated superior HbA1C and body weight reductions compared to Ozempic More: Lilly’s tirzepatide beats Ozempic in head-to-head type 2 diabetes trial Source: News
read morePositive CHMP opinion is based on results from the pivotal Phase II KarMMa study More: BMS’ CAR T therapy Abecma moves closer toward EU approval Source: News
read moreThe vaccine has been designed with minor genetic alterations to the spike protein based on the beta (B.1.351) variant More: AZ doses first participants with COVID-19 variant vaccine Source: News
read moreADA 2021: Novo trumpets higher-dose Ozempic data as Lilly competitors loom fkansteiner Sat, 06/26/2021 – 12:12 More: ADA 2021: Novo trumpets higher-dose Ozempic data as Lilly competitors loom Source: fierce
read moreCongressional Democrats launch probe into Biogen’s Aduhelm FDA approval, citing ‘serious concerns’ nhigginsdunn Fri, 06/25/2021 – 17:59 More: Congressional Democrats launch probe into Biogen's Aduhelm FDA approval, citing 'serious concerns' Source: fierce
read moreLilly’s COVID antibody combo halted nationwide, dealing huge blow to blockbuster program esagonowsky Fri, 06/25/2021 – 12:03 More: Lilly's COVID antibody combo halted nationwide, dealing huge blow to blockbuster program Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals